The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dame, T. M.
Right arrow Articles by Furie, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dame, T. M.
Right arrow Articles by Furie, M. B.
Right arrowPubmed/NCBI databases
*GEO DataSet
*Substance via MeSH
The Journal of Immunology, 2007, 178: 1172-1179.
Copyright © 2007 by The American Association of Immunologists, Inc.

IFN-{gamma} Alters the Response of Borrelia burgdorferi-Activated Endothelium to Favor Chronic Inflammation1

Tarah M. Dame*,{dagger}, Barbara L. Orenzoff{dagger}, Lance E. Palmer{dagger},{ddagger} and Martha B. Furie2,{dagger},{ddagger},§

* Graduate Program in Genetics, {dagger} Center for Infectious Diseases, {ddagger} Department of Molecular Genetics and Microbiology, and § Department of Pathology, School of Medicine, Stony Brook University, Stony Brook, NY 11794

Borrelia burgdorferi, the agent of Lyme disease, promotes proinflammatory changes in the endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-{gamma} in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-{gamma} on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-{gamma} synergistically augmented the expression of 34 genes, 7 of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1beta, TNF-{alpha}, and LPS also cooperated with IFN-{gamma} to induce synergistic production of CXCL10 by the endothelium, indicating that IFN-{gamma} potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed the endothelium exposed to B. burgdorferi and IFN-{gamma}, as compared with unstimulated endothelial monolayers. In contrast, addition of IFN-{gamma} diminished the migration of neutrophils across the B. burgdorferi-activated endothelium. IFN-{gamma} thus alters gene expression by endothelia exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants AI47313 and AI055621.

2 Address correspondence and reprint requests to Dr. Martha B. Furie, Center for Infectious Diseases, Stony Brook University, Room 240 CMM, Stony Brook, NY 11794-5120. E-mail address: Martha.Furie{at}stonybrook.edu

3 Abbreviations used in this paper: LD, Lyme disease; sp/EC, spirochetes per endothelial cell.

4 The online version of this article contains supplemental material.




This article has been cited by other articles:


Home page
CVIHome page
D. T. Nardelli, S. M. Callister, and R. F. Schell
Lyme Arthritis: Current Concepts and a Change in Paradigm
Clin. Vaccine Immunol., January 1, 2008; 15(1): 21 - 34.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.